Dr. Artemis P. Simopoulos is the founder and president of the Center for Genetics, Nutrition and Health, a nonprofit educational organization in Washington, DC, since 1990. Dr. Simopoulos was a founding member of the International Society for the Study of Fatty Acids and Lipids (ISSFAL) in 1991, secretary/treasurer of ISSFAL from 1991 to 1998, and a member of the editorial board of the ISSFAL newsletter from 1994 to 2000. She is the founder and president of the International Society of Nutrigenetics/ Nutrigenomics (ISNN) and founder and chair of the World Council on Nutrition, Fitness and Health (WCNFH) since 2005. A graduate of Barnard College in New York, with a major in chemistry, and a graduate of the Boston University School of Medicine, she is a physician and endocrinologist whose research at the National Institutes of Health (NIH) was on the nutritional aspects of genetic and endocrine disorders, evolutionary aspects of diet and fatty acids, and the importance of a balanced ratio of omega-6/omega-3 fatty acids in health and disease and in growth and development. She is the author of The Omega Diet (HarperCollins, 1999) and has edited numerous books and journal supplements, in addition to publishing over 300 scientific papers. She has been the editor of the Karger series World Review of Nutrition and Dietetics since 1989.
Dr. Holub is University Professor Emeritus, Department of Human Health & Nutritional Sciences at the University of Guelph. He received his B.Sc. degree from the University of Guelph (1967) and his Ph.D. (Major in Biochemistry with Minor in Nutrition) from the University of Toronto (1971). Dr. Holub received Post-doctoral training as an MRC Fellow at the University of Michigan Medical School. He has served as President, Nutrition Society of Canada and Chair, Nutrition Task Force (Heart & Stroke Foundation of Ontario). He has authored over 200 papers in scientific journals (medical, nutrition, other) in addition to various book chapters and conference proceedings. His research program is focused on dietary omega-3 fatty acids from fish/fish oils, plant oils, and resulting nutraceuticals plus functional foods for human health and the prevention/management of cardiovascular disease and other chronic disorders. As well, he has been active in the evaluation of nutraceuticals and agri-foods for improving human health, disease prevention and management, and their potential for considerable cost-savings to the healthcare system. He has also been studying the composition and health risks associated with foods containing ‘trans’ fatty acids. Dr. Holub also maintains active collaborative research with clinical groups at various Canadian medical schools, the Mayo Clinic in the United States, Japan, Greenland, and the agri-food sectors. Dr. Holub has spoken at over 300 off-campus events in over 15 countries. Dr. Holub has over 30 appearances on national TV in Canada (national news on CBC, CTV, Global). Dr.Holub has given over 200 interviews for various newspapers in Canada and the U.S. (Globe and Mail, Toronto Star, National Post, Montreal Gazette, Hamilton Spectator, etc) and magazines (Men’s Health, Prevention Magazine, Chatelaine, McLean ‘s, etc).
Professor Crawford has been the Director of the Institute of Brain Chemistry and Human Nutrition since 1990. He is now at Reproductive Physiology at the Chelsea and Westminster Hospital Campus of Imperial College, London. In 1963 he was one of the founders of the Medical College at Muhimbili Hospital in Dar-es-Salaam. He retained his research group at Makerere until 1972, when the position became impossible. His special interest lies is in the role that lipids and essential fatty acids play in interacting with the cellular signaling systems, i.e. the key interaction between nutrition affecting membrane lipids and gene expression. He has published over 300 peer reviewed papers and 3 books. Amongst his several honors and prizes, he was elected by his peers to the Hall of Fame at the Royal Society of Medicine in 2010. He collaborates in research internationally and is much in demand as a lecturer worldwide. Professor Crawford has been awarded the CHEVREUL medal in 2015 for his outstanding contribution to the identification of DHA as an important determinant in the evolution of the human brain and its fundamental role in brain growth and development.
CAPT Joseph Hibbeln is a Clinical Investigator and is the Acting Chief of the Laboratory of Membrane Biochemistry and Biophysics; Section of Nutritional Neuroscience (LMBB/SNN) at National Institute on Alcohol Abuse and Alcoholism(NIAAA). He has been the principal investigator of numerous studies at the NIH Clinical Center over the past 20 years. He has participated in extensive international collaborative clinical trials of omega-3 fatty acids for the prevention of suicide, postpartum depression, and violence. He is a primary collaborator in the Avon Longitudinal Study of Parents and Children, Bristol, UK, examining the residual effect of nutritional insufficiencies in pregnancy in childhood neurodevelopmental outcomes and relevant gene-nutrient interactions. Dr. Hibbeln was the originator of the field of omega-3 fatty acids in depressive disorders and for translating basic science findings into clinical trials. Dr. Hibbeln received a BA with special honors from the University of Chicago in 1983 and an M.D from the University of Illinois at Chicago, and completed his residency in Psychiatry at the University of California at Los Angeles. Among his numerous awards are the T.L Cleave Award from the McGarrison Society, the Gerald Klerman award from the National Association for Research in Schizophrenia and Depression, USPHS Crisis Response Awards for deployments in response to hurricanes and suicide clusters among Native Americans, and the Outstanding Service Medal, the third highest award in the USPHS.
Dr. Norman Salem, Jr. has been Chief Scientific Officer and Vice President of Martek Biosciences Corp. since February 4, 2008. Dr. Salem is one of the world’s leading researchers on DHA and the functions of polyunsaturated fatty acids and lipids. He joined to Martek after 30 years with The National Institutes of Health where he led the internationally recognized Laboratory of Membrane Biochemistry and Biophysics. His latest scientific work focused on the role of DHA in neural development as well as how DHA is made in the body and incorporated into the brain and other organs. Dr. Salem is responsible for leading clinical research, discovery, microbial biotechnology, and analytical sciences and support the efforts of scientific affairs and medical research. He serves as a Research Professor in the Department of Pediatrics at the F. Edward Hebert School of Medicine of Uniformed Services University of the Health Sciences. During his career, Dr. Salem has published over 200 research articles and book chapters. He was the 2002 recipient of the Supelco/Nicholas Pelick Research Award from the American Oil Chemists Society, which recognizes outstanding original research in fats, oils, lipid chemistry, or biochemistry. Dr. Salem received his B.S. degree in Physics from Miami University and his PhD in Neurobiology from the University Of Rochester School Of Medicine.
Dr. Richard P. Bazinet is a Professor of Departments of Nutritional Sciences at University of Toronto, and holds the Canada Research Chair in Brain Lipid Metabolism. Dr. Bazinet received the BSc from University of Western Ontario, PhD from University of Toronto, and Post-doctoral fellowship of Brain Physiology and Metabolism Section at National Institute on Aging of National Institutes of Health. He is a member of American Society for Neurochemistry, American Oil Chemists’ Society, Canadian Nutrition Society, and board member International Society for the Study of Fatty Acids and Lipids. His research focuses on identifying the mechanisms that regulate brain lipid metabolism (signaling) and identifying the role of brain lipid metabolism in the pathogenesis of neurodegenerative diseases and neuropsychiatric disorders, as well as investigating the role of dietary polyunsaturated fatty acids in rodent models of neuroinflammation and Alzheimer’s disease. He has published over 140 peer reviewed papers. Dr. Bazinet received the following awards: Early Career Award from International Society for the Study of Fatty Acids and Lipids in 2008; Jordi Folch-Pi Early Career Award from American Society for Neurochemistry in 2010; University of Toronto Early Career Faculty of Medicine Excellence in Graduate Teaching in 2011; Early Researcher Award from Ontario Ministry of Research and Innovation in 2011; Future Leaders Award from International Life Sciences Institute in 2011.
Dr. Jing X. Kang is Director of the Laboratory for Lipid Medicine and Technology (LLMT) at Massachusetts General Hospital/ Harvard Medical School and a Professor of Medicine at Harvard University. He is the Editor-in-Chief of the Journal of Nutrigenetics and Nutrigenomics (JNN), a founding board member and former Secretary of the International Society of Nutrigenetics and Nutrigenomics (ISNN), and a member of the World Council on Nutrition, Genetics, and Health. He is a “Changjiang Scholar” Chair Professor, appointed by the Ministry of Education of China, and an Honorary Professor of the PLA General Hospital (301 Hospital). He is also the author of one of China’s best-selling books, “How to Eat Well for Good Health”. Dr. Kang is a leading scientist in the field of omega-3 research, particularly in studying the role of the omega-6/omega-3 fatty acid ratio in health and disease. His lab has made several pioneering discoveries, including the prevention and treatment of cardiac sudden death by omega-3 fatty acids and the creation of a biotechnology for producing essential omega-3 fatty acids in animals. His lab has generated several unique transgenic animal models for omega-3 research. His seminal work has advanced our understanding of the differential effects of omega-6 and omega-3 fatty acids on chronic diseases, including cancer, cardiovascular disease, neurodegenerative disease, obesity and diabetes. His studies were listed among “Top 100 Science Stories” by Discover magazine. He was named one of “The Best and Brightest 2007” by Esquire magazine. To date, he has published more than 180 scientific papers in high-impact scientific journals including Nature, Science, and PNAS. His publications have been cited for more than 12,000 times with a H-index of 56. Dr. Kang has been invited to speak at more than 120 national and international meetings.
Dr. Strandvik is a professor of the Department of Biosciences and Nutrition at KarolinskaInstitutet in Sweden.
She is a pediatrician, nutritional biochemists, nutrition and diet expert. She has published more than 300 widely cited academic papers.
Dr. Duo Li is a professor of nutrition in the Department of Food Science & Nutrition, Zhejiang University. He has a Bachelor’s Degree in Medicine (Lanzhou University, China), and MSc (University of Tasmania, Hobart) in Natural Products and PhD in Nutrition (RMIT University, Melbourne) in Australia. He was also a research fellow at Deakin University, and a senior research fellow at RMIT University. He is a co-editor of the Asia Pacific Journal of Clinical Nutrition, associate editor of the Journal of Nutrigenetics & Nutrigenomics, editor of the Vegetarian Nutrition Journal, and has also served on numerous editorial boards. He is an expert consultant of FAO/WHO Expert Consultation on Human Nutrition, and WHO Expert Advisory Panel on Nutrition. He is a president of the Asia Pacific Clinical Nutrition Society, and immediate past-president of Asia Pacific Vegetarian Union. He is a member of China National Health Care Food Safety Committee of Experts, and a standing council member of Chinese Nutrition Society. Duo has published more than 430 scientific papers (more than 170 papers with impact factors), 9 books or book chapters and 18 inventive patents. Duo received Asia Pacific Clinical Nutrition Society Award in 2007; an Award for the Promotion of Student Nutrition and Health Tasks in 2004 in China. Duo has integrated research themes on nutrition in some five areas. The first is food bioactivity (anti-inflammation, anti-diabetes, anti-hypertension, anti-cancer, hypo-blood lipids etc) using whole foods, food ingredients, natural products, foods for health and functional foods, through in vitro studies, animal models and human clinical trials. The secondly is food safety evaluation, with an emphasis on the long term safety of foods. Third is the relationship between non-communicable diseases and habitual dietary intake. The fourth area is the evaluation of novel food and potential natural nutrient resources, through compositional and physiological studies. Finally, his work examines how nutrients, food ingredients and natural products influence the expression of select genes.
Mr. Zhengnian Luo is vice president of Shanghai Health Education Association, and chair of Shanghai Prospect Group. He graduated from the Sichuan Light Industry College, and Southwest University of Finance and Economics. Mr. Luo had been Vice President of Sichuan Textile Machinery Factory, General Manager of Hope Group and Chair of Shanghai Prospect Group. He organized the 2002 International Symposium of Essential Fatty Acids, Human Nutrition and Health, funded the 2004 China Xiangshan Scientific Conference inviting medical experts to discuss the cutting-edge scientific and technological achievements on Omega-3 fatty acids and initialized and organized the 2006 International Nutrition, Fitness and Health Conference in Shanghai. He is one of the main initiators of the Global Award for Omega-3 Research, and currently serves as the deputy director for the Management Committee of Omega-3 Award Fund in More Love Foundation.